1. Homepage
  2. Equities
  3. France
  4. Euronext Paris
  5. ERYTECH Pharma S.A.
  6. News
  7. All News
    ERYP   FR0011471135

ERYTECH PHARMA S.A.

(ERYP)
  Report
Real-time Euronext Paris  -  05/16 11:37:01 am EDT
1.140 EUR   -3.39%
05/13TRANSCRIPT : ERYTECH Pharma S.A., Q1 2022 Earnings Call, May 13, 2022
CI
05/12ERYTECH Provides Business and Financial Update for the First Quarter of 2022
GL
05/12ERYTECH Provides Business and Financial Update for the First Quarter of 2022
AQ
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector news
All news about ERYTECH PHARMA S.A.
05/13TRANSCRIPT : ERYTECH Pharma S.A., Q1 2022 Earnings Call, May 13, 2022
CI
05/12ERYTECH Provides Business and Financial Update for the First Quarter of 2022
GL
05/12ERYTECH Provides Business and Financial Update for the First Quarter of 2022
AQ
05/10European ADRs Move Higher in Tuesday Trading
MT
05/02European ADRs Move Slightly Lower in Monday Trading
MT
04/29European ADRs Nudge Higher in Friday Trading
MT
04/28ERYTECH Announces Filing of 2021 Universal Registration Document and 2021 Annual Report..
GL
04/28ERYTECH Announces Filing of 2021 Universal Registration Document and 2021 Annual Report..
AQ
04/28European ADRs Nudge Lower in Thursday Trading
MT
04/28ERYTECH PHARMA S A : ASSET PURCHASE AGREEMENT - Form 6-K
PU
04/27ERYTECH Pharma S.A. Reports Earnings Results for the Full Year Ended December 31, 2021
CI
04/26Top Midday Decliners
MT
04/26European ADRs Tumble in Tuesday Trading
MT
04/26ERYTECH SELLS U.S. MANUFACTURING FACILITY AND ENTERS LONG-TERM SUPPLY AGREEMENT WITH CA..
AQ
04/25ERYTECH PHARMA S A : Sells U.S. Manufacturing Facility and Enters Long-Term Supply Agreeme..
PU
04/25Top Midday Gainers
MT
04/25European ADRs Move Sharply Lower in Monday Trading
MT
04/25Wall Street Set to Extend Selloff on Aggressive Fed Tightening Concerns
MT
04/25Top Premarket Gainers
MT
04/25Erytech Pharma Divests US Manufacturing Plant For $45 Million; Stock Jumps 7%
MT
04/25ERYTECH Pharma Sells New Jersey Manufacturing Facility to Catalent for $44.5 Million
MT
04/25ERYTECH Sells U.S. Manufacturing Facility and Enters Long-Term Supply Agreement with Ca..
AQ
04/25Catalent, Inc. acquired Commercial-Scale Cell Therapy Development and Manufacturing Fac..
CI
04/25Catalent, Inc. acquired Cell therapy manufacturing facility in Princeton, New Jersey of..
CI
04/21European ADRs Move Slightly Higher in Thursday Trading
MT
04/19European ADRs Move Higher in Tuesday Trading
MT
04/18European ADRs Nudge Higher in Monday Trading
MT
04/12European ADRs Move Lower in Tuesday Trading
MT
04/11European ADRs Nudge Higher in Monday Trading
MT
04/08European ADRs Move Higher in Friday Trading
MT
04/07SECTOR UPDATE : Health Care Stocks Lead Afternoon Market Advance
MT
04/07SECTOR UPDATE : Health Care Stocks Posting Strong Gains This Afternoon
MT
04/07European ADRs Move Lower in Thursday Trading
MT
04/07Wall Street Set for Narrow Losses After Slump on Expectations of Hawkish Fed
MT
04/07Top Premarket Gainers
MT
04/06ERYTECH Pharma Says Phase 2 Trial Results of Eryaspase Published in Medical Journal
MT
04/06ERYTECH Announces Publication of Positive Results from Eryaspase Phase 2 Trial in Hyper..
AQ
04/06ERYTECH Pharma Announces Publication of Positive Results from Eryaspase Phase 2 Trial
CI
04/04ERYTECH to Present Novel Vesiculation Approach at the 24th Meeting of the European Red..
AQ
03/31European ADRs Move Lower in Thursday Trading
MT
03/30European ADRs Move Higher in Wednesday Trading
MT
03/29European ADRs Move Higher in Tuesday Trading
MT
03/28ERYTECH to Participate in the Upcoming April Investor Conferences
AQ
03/25European ADRs Nudge Higher in Friday Trading
MT
03/17European ADRs Nudge Higher in Thursday Trading
MT
03/16European ADRs Rise Sharply Higher in Wednesday Trading
MT
03/15European ADRs Move Higher in Tuesday Trading
MT
03/15ERYTECH PHARMA S A : Provides Business and Financial Update for the Fourth Quarter and Ful..
PU
03/14European ADRs Climb Higher in Monday Trading
MT
03/14Erytech provides business and financial update for the fourth quarter and full year 202..
AQ
03/14TRANSCRIPT : ERYTECH Pharma S.A., Q4 2021 Earnings Call, Mar 14, 2022
CI
03/11ERYTECH PHARMA S A : Provides Business and Financial Update for the Fourth Quarter and Ful..
PU
03/07European ADRs Move Lower in Monday Trading
MT
02/17European ADRs Move Sharply Lower in Thursday Trading
MT
02/10ERYTECH PHARMA S A : Expands Patent Portfolio for the Treatment of Rare Metabolic Diseases..
PU
02/09European ADRs Move Higher in Wednesday Trading
MT
02/08Erytech Secures US Patent For Red Blood Cell Platform's Use In Rare Metabolic Diseases
MT
02/08ERYTECH Expands Patent Portfolio for the Treatment of Rare Metabolic Diseases
AQ
02/08ERYTECH Pharma Expands Patent Portfolio for the Treatment of Rare Metabolic Diseases
CI
02/03European ADRs Move Lower in Thursday Trading
MT
01/28European ADRs Move Lower in Friday Trading
MT
01/27ERYTECH PHARMA S A : ▪Interim results from the Phase 1 rESPECT trial of eryaspase pl..
PU
01/25European ADRs Move Lower in Tuesday Trading
MT
01/25Erytech announces presentation of results of two clinical trials of eryaspase in pancre..
AQ
01/24Erytech Pharma Says Phase 1 Study of Pancreatic Cancer Drug Showed 'Encouraging' Clinic..
MT
01/24Erytech Pharma Logs Encouraging Clinical Activity In Pancreatic Cancer Treatment Trial
MT
01/24ERYTECH Announces Presentation of Results of Two Clinical Trials of Eryaspase in Panc..
AQ
01/24ERYTECH Pharma Announces Presentation of Results of Two Clinical Trials of Eryaspase in..
CI
01/03ERYTECH to Participate in the Upcoming January Virtual Investor Conferences
AQ
01/03European ADRs Move Higher in Monday Trading
MT
2021European ADRs Nudge Lower in Tuesday Trading
MT
2021ERYTECH PHARMA S A : ANNOUNCES PRESENTATION OF RESULTS OF EXPANDED ACCESS PROGRAM IN ALL A..
PU
2021Erytech announces $7.85 million registered direct offering
AQ
2021ERYTECH Pharma Expects to Raise $7.9 Million in Direct Offering of Units
MT
2021ERYTECH Announces Presentation of Results of Expanded Access Program in ALL at 2021 ASH..
AQ
1  2  3  4  5  6  7  8Next
Upcoming event on ERYTECH PHARMA S.A.